Modification of lung tumor development in A/J mice

Area of Science:

• Toxicology
• Carcinogenesis
• Pulmonary Medicine

Background:

• Butylated hydroxytoluene (BHT) is a synthetic antioxidant used in various products.
• The role of BHT in modulating chemically induced lung tumorigenesis requires further investigation.
• Understanding factors influencing lung cancer development is crucial for public health.

Purpose of the Study:

• To investigate the effect of butylated hydroxytoluene (BHT) on lung tumor formation induced by different carcinogens in mice.
• To determine if BHT's antioxidant properties or its cell proliferation-inducing capacity contribute to its effects on lung tumorigenesis.
• To explore the temporal relationship between BHT-induced lung injury and susceptibility to carcinogens.

Main Methods:

• Strain A mice were administered urethan, 3-methylcholanthrene, or dimethylnitrosamine.
• Mice received repeated injections of butylated hydroxytoluene (BHT), butylated hydroxyanisole (BHA), alpha-tocopherol (vitamin E), or methylcyclopentadienyl manganese tricarbonyl (MMT).
• Lung tumor multiplicity was assessed, and the susceptibility of lungs to urethan carcinogenicity following BHT-induced injury was evaluated.

Main Results:

• BHT treatment significantly increased the multiplicity of lung tumors induced by all three tested carcinogens.
• Other antioxidants (BHA, vitamin E) and methylcyclopentadienyl manganese tricarbonyl (MMT) did not enhance tumor formation.
• Lungs showed increased susceptibility to urethan carcinogenicity two weeks after BHT-induced injury, but not during acute proliferation.

Conclusions:

• The tumor-enhancing effects of BHT in mouse lungs are independent of its antioxidant activity.
• BHT's influence on lung tumor development is not attributable to its capacity to induce extensive cell proliferation.
• BHT may promote lung tumorigenesis through mechanisms other than antioxidant action or acute cell proliferation induction.